Trial Details
Not RecruitingBasic Information
| Clinical ID | c2399 |
|---|---|
| Identifier | EUCTR2016-001772-30-IT |
| Trial Title | Clinical burden of anemia in inflammatory bowel disease: Role of Iron Deficiency And iron Replacement Therapy, therapeutic trial - NA |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Anemia in inflammatory bowel disease MedDRA version: 20.1_Level: HLT_Classification code 10017921_Term: Gastrointestinal inflammatory disorders NEC_System Organ Class: 100000004856_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: FERLIXIT - 62.5 MG/5 ML SOLUZIONE PER USO ORALE E USO ENDOVENOSO 5 FIALE DA 5 ML Product Name: Ferro e.v. (come gluconato ferrico) Product Code: [NA] Pharmaceutical Form: Solution for infusion INN or Proposed INN: gluconato ferrico sodico Current Sponsor code: NA Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 12- Trade Name: FERINJECT - 50 MG/ML SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO IN VETRO DA 10 ML Product Name: Ferro e.v. (come carbossimaltoso ferrico) - FERINJECT Product Code: [NA] Pharmaceutical Form: Solution for infusion INN or Proposed INN: CARBOSSIMALTOSIO FERRICO Current Sponsor code: NA Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 50- |
Participant Information
| Sponsor | FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO |
|---|---|
| City | - |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |